Since the FDA approval of CA-125 as a tumor marker test, when a pelvic mass could be an ovarian carcinoma, clinicians are turning to this test as a tool in the diagnostic investigation.
The CA-125 test measures the level of cancer antigen 125 in the blood, primarily used as a marker for ovarian cancer.